Biotech

All Articles

ArsenalBio increases $325M, turns away from previous lead asset

.Arsenal Biosciences is actually going on up. The tissue treatment firm has added $325 million in am...

Lilly- supported fat loss biotech documents IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' cannabis make use of medicine flunks period 2b, driving Indivior to reconsider $100M possibility

.Aelis Farma's chances of securing a fast, good decision on a $one hundred thousand possibility repa...

ProKidney standstills stage 3 test certainly not needed to have for cell therapy confirmation

.ProKidney has actually quit some of a set of stage 3 trials for its cell treatment for renal ailmen...

Vaxcyte rises on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals called "sensational" stage 1/2 data for its 31-valent pneumococ...

Recursion's mind condition trial shows insufficient proof of efficacy

.Recursion has stumbled with a very early examination of its own tech-enabled technique to drug reve...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Contact it a situation of great chemistry: Acepodia, a biotech based on Nobel Prize-winning science...

Praxis epilepsy drug lowers confiscations in stage 2 trial

.Practice Precision Medicines has actually scored one more midphase gain in epilepsy this year, alon...

Three directors resign as Dyne messages blended information for DMD candidate

.After getting away a clinical hold several years back, Dyne Rehab has actually revealed brand new p...

Arrowhead fires off period 3 information in rare metabolic health condition before market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in advance of a possible face-off along with ...